Govt plans Rs 10k cr VC fund to promote R&D in pharma

Image
Press Trust of India New Delhi
Last Updated : Jan 21 2013 | 3:38 AM IST

The Government is planning to set up a Rs 10,000 crore venture capital (VC) fund for financing new drug discovery projects in the country.

"We will soon invite bids from consultancy firms for establishing a venture capital fund in public-private- -partnership that would finance research and development (R&D) activities in the pharmaceutical segment," Department of Pharmaceuticals Secretary Ashok Kumar told reporters on the sidelines of a Ficci event.

The department will soon invite bids from advisors to prepare a detailed project report on the proposed fund, Kumar said.

The initial target will be to raise up to Rs 3,000 crore by 2011-12, and it would be gradually increased to Rs 10,000 crore by 2015, he added.
    
National Institute of Public Finance and Policy (NIPFP) is advising the department in the process of selecting an agency to design the fund.
    
Kumar said that though the government aims to make India a hub for new drug development activities, no institutional funding is currently available for the purpose in the country.
    
According to information available, the country spends about Rs 2,000 crore every year on R&D. While the government contributes Rs 500 crore to this, the rest comes from the private sector.
    
The proposed funding of Rs 10,000 crore, which includes substantial contribution from the private pharma industry under the public private partnership (PPP) model, is likely to bring about a favourable environment for drug innovation, Kumar said.
    
Last year, the department of pharmaceuticals had prepared a white paper on promoting research and development funding in the country, and submitted the proposal to the Prime Minister's Office for approval.
    
"The present state of infrastructure and research and development of the pharma industry in the country is rather weak," Kumar said.
    
As per the proposal, the government intends to undertake pro-active steps on four fronts, building infrastructure for talent and research, encouraging public-private partnerships in infrastructure development, providing financial incentives to encourage innovation, and shaping a favourable regulatory environment.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 12 2010 | 3:59 PM IST

Next Story